4.6 Article

Antibacterial Potential of Termite-Associated Streptomyces spp

Journal

ACS OMEGA
Volume 6, Issue 6, Pages 4329-4334

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsomega.0c05580

Keywords

-

Funding

  1. National Natural Science Foundation of China [31770007]
  2. Graduate Innovation Fund of Anhui Agricultural University [2020ysj-52]

Ask authors/readers for more resources

Among the twenty-one strains of termite-associated actinomycetes tested, nine showed bacteriostatic activities, with strain YH01 isolated from the queen of Odontotermes formosanus exhibiting potent antibacterial activity. The metabolite roseoflavin from YH01 demonstrated strong inhibition against Gram-positive bacteria, particularly MRSA, while also displaying no effect on Gram-negative bacteria.
Twenty-one strains of termite-associated actinomycetes were tested for their activities against three bacteria. The results showed that nine strains showed bacteriostatic activities against at least one tested bacterium, and the actinomycete YH01, which was isolated from the body surface of the queen of Odontotermes formosanus, had potent antibacterial activity. The YHO1 was further identified as Streptomyces davaonensis. Two metabolites roseoflavin (1) and 8-methylamino-8-demethyl-D-riboflavin (2) were isolated and purified from S. davaonensis YH01. Their structures were determined by NMR, MS, and the related literature. The metabolite 1 showed strong inhibition activities against Bacillus subtilis (MIC = 1.56 mu g/mL) and Staphylococcus aureus (MIC = 3.125 mu g/mL), which were comparable to referenced gentamycin sulfate, with MIC values of 1.56 and 1.56 mu g/mL, respectively. Furthermore, the anti-MRSA potential of compound 1 was determined against nine kinds of MRSA strains, with inhibition zones in the ranges of 12.7-19.7 mm under a concentration of 15 mu g/6 mm discs and 18.3-22.7 mm under a concentration of 30 mu g/6 mm discs. However, metabolite 1 had no inhibitory effect on Gram-negative bacteria. These results suggested that roseoflavin produced by YH01 holds promise for use against Gram-positive bacteria, especially to MRSA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available